Public Profile

Ipca Laboratories

Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management. With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.

DitchCarbon Score

How does Ipca Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Ipca Laboratories's score of 26 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

40%

Let us know if this data was useful to you

Ipca Laboratories's reported carbon emissions

In 2023, Ipca Laboratories reported carbon emissions of approximately 124,880,000 kg CO2e for Scope 1 and about 179,114,000 kg CO2e for Scope 2. This reflects a consistent emission pattern from the previous year, with similar figures reported in 2022. However, in 2024, there was a notable increase in Scope 1 emissions to approximately 174,538,000 kg CO2e, while Scope 2 emissions decreased to about 137,345,000 kg CO2e. Ipca Laboratories has committed to a significant reduction target, aiming for a 20% decrease in carbon emissions across both Scope 1 and Scope 2 by 2030. This commitment underscores the company's dedication to enhancing its sustainability practices and reducing its carbon footprint in alignment with industry standards. The reduction targets are set to begin from 2023, indicating a proactive approach to climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
124,880,000
000,000,000
000,000,000
Scope 2
179,114,000
000,000,000
000,000,000
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipca Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ipca Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Ipca Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Alkem Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Alembic Pharmaceuticals

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Abbott India Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Wockhardt

IN
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Dr Reddys Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Zydus Lifesciences

IN
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers